Preliminary scientific tests indicate conolidine might inhibit distinct ion channels, reducing neuronal excitability and restricting suffering indicators. This mechanism is particularly appropriate in neuropathic agony, the place abnormal signaling results in persistent soreness. Furthermore, conolidine seems to affect G protein-coupled receptor (GPCR) pathways integral to agony perce... https://kirki405gyo3.wikiusnews.com/user